Vinblastine Export Market Intelligence: India's 140 Suppliers Shipping to 96 Countries — TransData Nexus 2026

Q: Who are the top vinblastine exporters from India?

The top vinblastine exporters from India are: 1. NAPROD LIFE SCIENCES PRIVATE LIMITED — $128.5K (17.1% market share); 2. SP ACCURE LABS PRIVATE LIMITED — $98.2K (13.1% market share); 3. UNITED BIOTECH PRIVATE LIMITED — $47.8K (6.4% market share); 4. ADVANOV PHARMA PRIVATE LIMITED — $45.7K (6.1% market share); 5. AXA PARENTERALS LIMITED — $37.1K (4.9% market share). Together they account for 47.6% of India's total vinblastine export value.

Q: What is the total export value of vinblastine from India?

The total export value of vinblastine from India is $750.1K USD, recorded across 573 shipment transactions from 140 active exporters to 96 destination countries. The average shipment value is $1.3K.

Q: Which countries import vinblastine from India?

India exports vinblastine to 96 countries worldwide. The top importing countries are: COLOMBIA (9.6% share, $72.2K), IRAN (9.3% share, $70.0K), POLAND (8.0% share, $59.7K), THAILAND (7.9% share, $59.3K), VENEZUELA (6.4% share, $48.1K). These five markets account for 41.2% of total export value.

Q: What is the HS code for vinblastine exports from India?

The primary HS code for vinblastine exports from India is 30049043. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of vinblastine exports from India?

The average unit price for vinblastine exports from India is $3.98 USD per unit, with prices ranging from $0.01 to $69.19 depending on formulation, packaging, and order volume. The total market is valued at $750.1K across 573 shipments.

Q: Which ports handle vinblastine exports from India?

The primary ports for vinblastine exports from India are SAHAR AIR (22.3% of shipments), SAHAR AIR CARGO ACC (INBOM4) (22.2% of shipments), Bombay Air (10.6% of shipments), DELHI AIR (7.9% of shipments), DELHI AIR CARGO ACC (INDEL4) (6.3% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of vinblastine?

India is one of the world's leading exporters of vinblastine due to its large base of 140 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports vinblastine to 96 countries, demonstrating 49% global market coverage.

Q: What certifications do Indian vinblastine exporters need?

Indian vinblastine exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import vinblastine from India?

There are 244 registered buyers importing vinblastine from India, spread across 96 countries. The repeat buyer rate is 38.1%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top vinblastine supplier from India?

NAPROD LIFE SCIENCES PRIVATE LIMITED is the leading vinblastine exporter from India with a market share of 17.1% and total export value of $128.5K across 5 shipments. The top 5 suppliers together control 47.6% of total export value.

Suresh Sormare

Vinblastine

India Pharmaceutical Trade Intelligence

$750.1K140 Suppliers96 CountriesHS 30049043

ExportsIndia → COLOMBIA9.6%India → IRAN9.3%

ImportsAUSTRALIA → India$1.1K

#1 Supplier: NAPROD LIFE

Vinblastine Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Vinblastine to the World

Between 2022 and 2026, India exported $750.1K worth of vinblastine across 573 verified shipments to 96 countries — covering 49% of world markets in the Advanced Oncology segment. The largest destination is COLOMBIA (9.6%). NAPROD LIFE SCIENCES PRIVATE LIMITED leads with a 17.1% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Vinblastine export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Vinblastine export data snapshot — $750.1K · 140 exporters · 96 countriesTransData Nexus · Indian Customs Data

Top Vinblastine Exporters from India

140 active exporters · Ranked by export value

View all 140 →

Top Vinblastine Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	NAPROD LIFE SCIENCES PRIVATE LIMITED	$128.5K	5	3	17.1%
2	SP ACCURE LABS PRIVATE LIMITED

Top Countries Importing Vinblastine from India

96 destination markets · Ranked by import value

All 96 countries →

Top Countries Importing Vinblastine from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	COLOMBIA	$72.2K	9.6%
2	IRAN	$70.0K	9.3%
3	POLAND	$59.7K	8.0%
4	THAILAND	$59.3K	7.9%
5	VENEZUELA	$48.1K	6.4%
6	CHILE	$44.1K	5.9%
7	BELARUS	$40.9K	5.5%
8	LEBANON	$32.4K	4.3%
9	SRI LANKA	$24.0K	3.2%
10	KENYA	$21.9K	2.9%

COLOMBIA is India's largest vinblastine export destination, absorbing 9.6% of total exports worth $72.2K. The top 5 importing countries — COLOMBIA, IRAN, POLAND, THAILAND, VENEZUELA — together account for 41.2% of India's total vinblastine export value. The remaining 91 destination countries collectively receive the other 58.8%, indicating a broadly diversified export footprint across multiple regions.

Who Supplies Vinblastine to India?

1 origin countries · Total import value: $1.1K

India imports vinblastine from 1 countries with a combined import value of $1.1K. The largest supplier is AUSTRALIA ($1.1K, 2 shipments), followed by . All values are from Indian Customs (DGFT) import records.

Countries Supplying Vinblastine to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	AUSTRALIA	$1.1K	2	100.0%

AUSTRALIA is the largest supplier of vinblastine to India, accounting for 100.0% of total import value. Click any country to see detailed supplier and buyer data for that import corridor.

Regulatory Landscape — Vinblastine

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

In the United States, Vinblastine sulfate is approved for use in the treatment of various cancers. The FDA's Orange Book lists multiple approved Abbreviated New Drug Applications (ANDAs) for Vinblastine sulfate, indicating the presence of generic versions in the market. The regulatory pathway for Vinblastine involves stringent evaluation of safety, efficacy, and manufacturing quality. Given the substantial number of Indian exporters (140) involved in Vinblastine exports, it is imperative for these entities to ensure compliance with FDA regulations, including adherence to Good Manufacturing Practices (GMP) and successful completion of the ANDA process, to access the U.S. market.

2EU & UK Regulatory Framework

In the European Union, the European Medicines Agency (EMA) oversees the approval and regulation of medicinal products, including Vinblastine. Marketing authorization requires comprehensive data on quality, safety, and efficacy. Similarly, in the United Kingdom, the Medicines and Healthcare products Regulatory Agency (MHRA) is responsible for the regulation of medicines. Both agencies mandate compliance with EU Good Manufacturing Practice (GMP) guidelines, ensuring that products meet the required quality standards. Indian exporters targeting these markets must obtain the necessary marketing authorizations and demonstrate adherence to GMP standards to ensure market access.

3WHO Essential Medicines & Global Standards

Vinblastine is included in the WHO Model List of Essential Medicines, underscoring its importance in global health. The 2025 edition of the WHO Model List includes over 520 medicines, reflecting the critical role of essential medicines in addressing priority health needs. Inclusion in this list signifies that Vinblastine is considered essential for meeting the priority health care needs of populations worldwide. Additionally, Vinblastine must comply with international pharmacopoeia standards, including those set forth by the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP), ensuring consistent quality and efficacy across different markets.

4India Regulatory Classification

In India, Vinblastine is classified under Schedule H of the Drugs and Cosmetics Act, indicating that it is a prescription drug requiring medical supervision. The National Pharmaceutical Pricing Authority (NPPA) regulates the pricing of essential medicines to ensure affordability. As of the latest available data, the ceiling price for Vinblastine has been set to make it accessible to patients. For exports, the Directorate General of Foreign Trade (DGFT) mandates a No Objection Certificate (NOC) for certain pharmaceutical products, ensuring that domestic needs are met before exportation. Exporters must comply with these regulations to facilitate smooth international trade.

5Patent & Exclusivity Status

The primary patents for Vinblastine have expired, allowing for the production and distribution of generic versions. This has led to increased competition among manufacturers, including those from India, contributing to the availability of cost-effective treatment options globally. The absence of active patents facilitates broader access to this essential medication, benefiting patients worldwide.

6Recent Industry Developments

In May 2025, the WHO Expert Committee on Selection and Use of Essential Medicines convened to update the Model List of Essential Medicines, reaffirming the inclusion of Vinblastine due to its critical role in cancer treatment. This underscores the ongoing global recognition of Vinblastine's importance in oncology.

In January 2026, the WHO published a fact sheet emphasizing the significance of essential medicines, including Vinblastine, in addressing priority health care needs. The document highlighted the necessity for these medicines to be available, affordable, and of assured quality at all times, aligning with the objectives of universal health coverage. (who.int)

These developments reflect the continuous efforts by international health organizations to ensure the accessibility and quality of essential medicines like Vinblastine, reinforcing their pivotal role in global health initiatives.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Vinblastine

Retail & reference prices across 9 markets vs. India FOB export price of $3.98/unit

Global Price Benchmark for Vinblastine across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	N/A	USD	Pricing information for vinblastine sulfate injection is not readily accessible through public FDA resources.
United Kingdom	N/A	GBP	The NHS Drug Tariff does not list a specific price for vinblastine sulfate injection.
Germany	N/A	EUR	The Federal Institute for Drugs and Medical Devices (BfArM) does not provide public pricing information for vinblastine sulfate injection.
Australia	N/A

Supply Chain Risk Assessment — Vinblastine

API sourcing, concentration risk, storage requirements, and current alerts

MEDIUM RISK

1API Sourcing & Raw Material Dependency

Vinblastine is derived from the Catharanthus roseus plant, primarily cultivated in regions like Madagascar. The yield of this plant is highly sensitive to climatic conditions, soil quality, and disease pressures, making the supply chain vulnerable to environmental disruptions. Additionally, the extraction process is labor-intensive and requires skilled personnel, further complicating the supply chain.

India's pharmaceutical industry heavily relies on China for Key Starting Materials (KSMs) and Active Pharmaceutical Ingredients (APIs). Approximately 70% of APIs used in India are imported from China, highlighting a significant dependency. This reliance poses risks, especially when geopolitical tensions or regulatory changes affect the supply chain.

2Supplier Concentration & Single-Source Risk

The top five exporters of Vinblastine from India account for 47.6% of the market share, with NAPROD LIFE SCIENCES PRIVATE LIMITED leading at 17.1%. This concentration indicates a moderate risk, as disruptions affecting these key suppliers could impact the overall supply chain.

To mitigate such risks, the Indian government has implemented the Production Linked Incentive (PLI) scheme, aiming to boost domestic production of critical APIs and reduce dependency on imports. In October 2024, two greenfield plants were inaugurated under this scheme to manufacture essential molecules used in common antibiotics, marking a significant step towards self-reliance.

Access Complete Vinblastine Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 573 transactions across 96 markets.

Request Demo View Pricing

Frequently Asked Questions — Vinblastine Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top vinblastine exporters from India?

The leading vinblastine exporters from India are NAPROD LIFE SCIENCES PRIVATE LIMITED, SP ACCURE LABS PRIVATE LIMITED, UNITED BIOTECH PRIVATE LIMITED, and 11 others. NAPROD LIFE SCIENCES PRIVATE LIMITED leads with 17.1% market share ($128.5K). The top 5 suppliers together control 47.6% of total export value.

What is the total export value of vinblastine from India?

The total export value of vinblastine from India is $750.1K, recorded across 573 shipments from 140 active exporters to 96 countries. The average shipment value is $1.3K.

Which countries import vinblastine from India?

India exports vinblastine to 96 countries. The top importing countries are COLOMBIA (9.6%), IRAN (9.3%), POLAND (8.0%), THAILAND (7.9%), VENEZUELA (6.4%), which together account for 41.2% of total export value.

What is the HS code for vinblastine exports from India?

The primary HS code for vinblastine exports from India is 30049043. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Vinblastine

Vinblastine

Top Vinblastine Exporters from India

Top Countries Importing Vinblastine from India

Who Supplies Vinblastine to India?

Quick Facts

Related Advanced Oncology

Related Analysis

Need Details?

Regulatory Landscape — Vinblastine

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Vinblastine

Supply Chain Risk Assessment — Vinblastine

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Vinblastine Trade Intelligence

Frequently Asked Questions — Vinblastine Exports from India

Who are the top vinblastine exporters from India?

What is the total export value of vinblastine from India?

Which countries import vinblastine from India?

What is the HS code for vinblastine exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of vinblastine exports from India?

Which ports handle vinblastine exports from India?

Why is India a leading exporter of vinblastine?

What certifications do Indian vinblastine exporters need?

How many buyers import vinblastine from India?

What is the market share of the top vinblastine exporter from India?

Analysis Methodology